Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI)

NCT: NCT04969471 · ACTIVE_NOT_RECRUITING

NCT IDNCT04969471
StatusACTIVE_NOT_RECRUITING
Start Date2021-12-09
Completion2027-08-01

Brief Summary

This study is designed to compare the safety and effectiveness of blood clot (thrombus) removal in subjects presenting with ST-segment elevation myocardial infarction (STEMI) with the enVast coronary system versus conventional intervention.

Frequently Asked Questions

What is NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI)?

NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI) is a clinical trial registered under NCT04969471. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04969471?

The current status of NCT04969471 (NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI)) is: ACTIVE_NOT_RECRUITING.

When did NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI) start?

NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI) started on 2021-12-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑